← Back to Clinical Trials
Recruiting NCT06788873

NCT06788873 Comparison of Cervical Cerclage by Vaginal and by Laparoscopic Transabdominal Routes in the Periconceptional Period

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06788873
Status Recruiting
Phase —
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition Cerclage, Cervical
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2022-05-15
Primary Completion 2026-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 44 Years
Study Type OBSERVATIONAL
Interventions
Data comparison

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2022-05-15 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to compare two different surgical techniques of performing elective cervical cerclage in the prevention of preterm delivery, both of which are already widely used in common clinical practice: elective cervical cerclage by the vaginal route and laparoscopic transabdominal elective cervical cerclage.

Eligibility Criteria

Inclusion Criteria: * Patients with unfavorable obstetric history, i.e., at least two previous preterm deliveries or second-trimester abortions who underwent elective prophylactic cervical cerclage (vaginal or laparoscopic) between 01/01/2002 and 31/12/2020 * Age ≥18 years * Obtaining informed consent form * Availability of clinical-demographic data Exclusion Criteria: * Multiple pregnancy

Contact & Investigator

Central Contact

Elisa Montaguti, MD

✉ elisa.montaguti@aosp.bo.it

📞 0512144369

Principal Investigator

Elisa Montaguti, MD

PRINCIPAL INVESTIGATOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Frequently Asked Questions

Who can join the NCT06788873 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 44 Years, studying Cerclage, Cervical. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06788873 currently recruiting?

Yes, NCT06788873 is actively recruiting participants. Contact the research team at elisa.montaguti@aosp.bo.it for enrollment information.

Where is the NCT06788873 trial being conducted?

This trial is being conducted at Bologna, Italy.

Who is sponsoring the NCT06788873 clinical trial?

NCT06788873 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Elisa Montaguti, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology